ONCY:NASDAQ
Oncolytics Biotech Inc
$0.55
arrow_upward
+0.57%(+0.0031) 1D
Oct 9, 12:25:43 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.55
High
$0.55
Low
$0.52
Mkt. cap
72.37M
Avg. vol.
1.05M
Volume
629.16K
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.55
High
$0.55
Low
$0.52
Mkt. cap
72.37M
Avg. vol.
1.05M
Volume
629.16K
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
BigGo Finance
·
43 minutes ago
Dow extends gains, climbs back above 51,300 on tech buybacks; SpaceX briefly up 3%
36Kr
·
44 minutes ago
Can the US Stock Bull Market Still Continue? 2025 Outlook, Key Drivers & Future Trend Analysis
ChartMill
·
2 hours ago
These S&P500 stocks are gapping in today's session
The Motley Fool
·
31 minutes ago
I've Owned the Vanguard S&P 500 ETF for 6 Years. Here's Why I'm Not Selling.
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com